NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
NeoGenomicsNeoGenomics(US:NEO) Businesswire·2026-03-16 19:05

公司产品与监管进展 - 公司旗下名为PanTracer™ LBx的检测产品已获得美国联邦医疗保险和医疗补助服务中心的分子诊断服务项目覆盖 [1]

NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling - Reportify